SAFETY OF LISOCABTAGENE MARALEUCEL GIVEN WITH DURVALUMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B‐CELL NON HODGKIN LYMPHOMA: FIRST RESULTS FROM THE PLATFORM STUDY.

Autor:	Siddiqi, T., Abramson, J.S., Lee, H.J., Schuster, S., Hasskarl, J., Montheard, S., Dell Aringa, J., Thompson, E., Ananthakrishnan, R., Lunning, M.
Předmět:	HODGKIN'S disease CHIMERIC antigen receptors
Zdroj:	Hematological Oncology; Jun2019 Supplement S1, Vol. 37, p171-172, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text